Item 9 Labs Corp (INLB)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 15, 09:30
Item 9 Labs Total Liabilities (Quarterly): 59.37M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 59.37M |
| March 31, 2023 | 56.44M |
| December 31, 2022 | 54.31M |
| September 30, 2022 | 48.82M |
| June 30, 2022 | 42.02M |
| March 31, 2022 | 38.11M |
| December 31, 2021 | 32.56M |
| September 30, 2021 | 30.71M |
| June 30, 2021 | 14.31M |
| March 31, 2021 | 14.98M |
| December 31, 2020 | 12.78M |
| September 30, 2020 | 12.65M |
| June 30, 2020 | 11.35M |
| March 31, 2020 | 10.40M |
| December 31, 2019 | 9.075M |
| September 30, 2019 | 7.138M |
| June 30, 2019 | 5.372M |
| September 30, 2018 | 0.8952M |
| March 31, 2018 | 0.7544M |
| December 31, 2017 | 1.954M |
| September 30, 2017 | 0.0523M |
| June 30, 2017 | 2.282M |
| March 31, 2017 | 2.261M |
| Date | Value |
|---|---|
| December 31, 2016 | 2.219M |
| September 30, 2016 | 2.162M |
| June 30, 2016 | 5.313M |
| March 31, 2016 | 5.147M |
| December 31, 2015 | 5.119M |
| September 30, 2015 | 5.097M |
| June 30, 2015 | 4.569M |
| March 31, 2015 | 4.030M |
| December 31, 2014 | 3.569M |
| September 30, 2014 | 3.145M |
| June 30, 2014 | 2.804M |
| March 31, 2014 | 2.529M |
| December 31, 2013 | 4.290M |
| September 30, 2013 | 3.380M |
| June 30, 2013 | 3.353M |
| March 31, 2013 | 3.258M |
| December 31, 2012 | 3.021M |
| June 30, 2012 | 2.997M |
| March 31, 2012 | 2.981M |
| December 31, 2011 | 0.005M |
| September 30, 2011 | 0.0695M |
| December 31, 2010 | 0.0431M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.372M
Minimum
Jun 2019
59.37M
Maximum
Jun 2023
27.08M
Average
14.98M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| Humanigen Inc | 54.84M |
| Cantabio Pharmaceuticals Inc | 2.215M |
| Affymax Inc | -- |
| Scopus BioPharma Inc | 11.00M |
| Statera BioPharma Inc | 22.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 112.02M |
| Shareholders Equity (Quarterly) | 52.65M |
| Debt to Equity Ratio | 0.6439 |
| Current Ratio | 0.0569 |
| Net Debt Paydown Yield | -30.33% |